Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Cancers|July 24, 2021
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, et al.
International Journal of Molecular Sciences|April 13, 2024
Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune MicroenvironmentMathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, et al.
Journal of Clinical Medicine|October 10, 2020
CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell CarcinomaEric Remer, Mai Badarni, Elad Hikri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cellsMoshe Elkabets, Yakov Krelin, Shahar Dotan, et al.
Molecular Cancer|May 9, 2025
N-glycosylation of PD-L1 modulates the efficacy of immune checkpoint blockades targeting PD-L1 and PD-1Bar Kaufman, Muhammad Abu-Ahmad, Olga Radinsky, et al.
Frontiers in Oncology|February 7, 2019
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted TherapySusmita Ghosh, Manu Prasad, Kiran Kundu, et al.
International Journal of Cancer|January 30, 2019
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancerOfra Novoplansky, Matthew Fury, Manu Prasad, et al.
The Journal of Clinical Investigation|January 27, 2011
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in miceMoshe Elkabets, Ann M Gifford, Christina Scheel, et al.
Cancer Immunology Research|June 6, 2019
Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNAKiran Kundu, Susmita Ghosh, Rhitajit Sarkar, et al.
Plos One|September 3, 2011
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talkShirin Elhaik-Goldman, Daniel Kafka, Rami Yossef, et al.
Pageof 9